LeBas (HB 391) Act No. 282
Existing law provides for the creation of the La. Board of Pharmacy (the board) within the
Dept. of Health and Hospitals.
Prior law provided for the powers and duties to be held by the board.
New law retains prior law and further authorizes the board to assess and collect expenses
incurred for the inspection of nonresident licensees.
Prior law classified pharmacies located outside of this state as "out-of-state pharmacies".
New law changes the term to "nonresident pharmacists".
Prior law required an out-of-state pharmacy to which the board has granted an out-of-state
pharmacy permit to disclose to the board the location, names, and titles of all principal
corporate officers of the out-of-state pharmacy.
New law retains prior law and adds that the nonresident pharmacy must also disclose the
location, names, and titles of the nonresident pharmacy owner's managing officer and
pharmacist-in-charge.
Prior law required a report containing this information to be made to the board on an annual
basis and within 30 days after any change of office, corporate officer, or within 10 days of
the departure of the prior pharmacist-in-charge.
New law requires a report containing this information to be made to the board on an annual
basis and within 30 business days after any change of office, corporate officer, or within 10
business days of the departure of the prior owner's managing officer or pharmacist-in-charge.
Prior law required an out-of-state pharmacy seeking an out-of-state pharmacy permit from
the board to submit a copy of the most recent inspection report from any inspection
conducted by the regulatory or licensing agency of the state in which it is located.
New law retains prior law, but further requires the nonresident pharmacy to also submit any
other inspection reports produced by the Food and Drug Administration or the Drug
Enforcement Administration.
New law also requires the nonresident pharmacy to submit any reports from any other state
pharmacy licensing agency that has conducted an inspection in the state in which it is
located.
Prior law required an out-of-state pharmacist, after the grant of an out-of-state pharmacist
permit, to submit copies to the board of any subsequent inspection reports on the pharmacy
that are conducted by the regulatory or licensing body of the state in which it is located.
New law retains prior law and further requires the nonresident pharmacy, after the grant of
a nonresident pharmacy permit, to also submit any other inspection reports produced by the
Food and Drug Administration or the Drug Enforcement Administration.
New law provides that in addition to, or in lieu of, any inspections conducted by the
regulatory or licensing body of the state in which it is a resident, upon the board's grant of
a nonresident permit, the nonresident pharmacy shall become subject to inspections by the
board.
New law provides that the expense of such inspection shall be attributed to the nonresident
pharmacy.
Effective August 1, 2013.
(Amends R.S. 37:1232; Adds R.S. 37:1182(B)(9))